At a glance
ClinicalIndex Comparison RecordN/ACompleted· 47 enrolled
Drug / intervention
i-cor Synchronized Cardiac Assist Devicedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Synchronized Cardiac Assist for Cardiogenic Shock. The SynCor Trial
In Brief
An observational study evaluating i-cor Synchronized Cardiac Assist Device for Shock, Cardiogenic and High Risk Percutaneous Coronary Interventions. Completed, enrolled 47 participants across 1 site.
Detailed Summary
The purpose of this study is to collect prospective safety and performance information for the i-COR® device using synchronized cardiac assist in the setting of combined heart-lung failure or in high risk percutaneous intervention procedures in catheterization lab.
Study Details
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartJan 2016
First PostedMar 2016
Primary CompletionApr 2018
Study CompletionFeb 2019
TodayJul 2026
First PostedMar 2, 2016
Enrollment StartJan 1, 2016
Primary CompletionApr 30, 2018
Study CompletionFeb 16, 2019
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 10.3 years ago
Interventions
i-cor Synchronized Cardiac Assist Devicedevice
The i-cor Synchronized Cardiac Assist Device delivers pulsatile cardiac assist synchronized to the ECG during diastole and provides enhanced oxygenation through a membrane oxygenator.